Literature DB >> 24868594

Essential role for the SLK protein kinase in embryogenesis and placental tissue development.

Khalid N Al-Zahrani, Prabhjot Sekhon, Daniel R Tessier, Julien Yockell-Lelievre, Benjamin R Pryce, Kyla D Baron, Grant A Howe, Roshan K Sriram, Kate Daniel, Marlene Mckay, Vivian Lo, Jennifer Quizi, Christina L Addison, Andrée Gruslin, Luc A Sabourin.   

Abstract

BACKGROUND: Over the past decade, the Ste20-like kinase SLK, has been implicated in several signaling processes. SLK repression has been shown to impair cell cycle kinetics and inhibit FAK-mediated cell migration. Here, using a gene trapped allele, we have generated mice expressing a truncated form of the SLK kinase.
RESULTS: Our results show that an SLK-LacZ fusion protein is expressed in embryonic stem cells and in embryos throughout development. We find that the SLK-LacZ fusion protein is less efficient at phosphorylating substrates resulting in reduced cell proliferation within the embryos and angiogenic defects in the placentae of the homozygous mutant animals at embryonic day (E) 12.5. This results in marked developmental defects and apoptotic lesions in the embryos by E14.5.
CONCLUSIONS: Homozygotes expressing the SLK-LacZ fusion protein present with an embryonic lethal phenotype occurring between E12.5 and E14.5. Overall, we demonstrate a requirement for SLK kinase activity in the developing embryo and placenta.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24868594     DOI: 10.1002/dvdy.24106

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  6 in total

1.  Ste20-like kinase, SLK, a novel mediator of podocyte integrity.

Authors:  Andrey V Cybulsky; Joan Papillon; Julie Guillemette; Natalya Belkina; Genaro Patino-Lopez; Elena Torban
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

2.  Ste20-like Kinase Is Critical for Inhibitory Synapse Maintenance and Its Deficiency Confers a Developmental Dendritopathy.

Authors:  Susanne Schoch; Anne Quatraccioni; Barbara K Robens; Robert Maresch; Karen M J van Loo; Silvia Cases-Cunillera; Tony Kelly; Thoralf Opitz; Valeri Borger; Dirk Dietrich; Julika Pitsch; Heinz Beck; Albert J Becker
Journal:  J Neurosci       Date:  2021-08-16       Impact factor: 6.167

3.  Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.

Authors:  Grant A Howe; Bin Xiao; Huijun Zhao; Khalid N Al-Zahrani; Mohamed S Hasim; James Villeneuve; Harmanjatinder S Sekhon; Glenwood D Goss; Luc A Sabourin; Jim Dimitroulakos; Christina L Addison
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

4.  Regulation of Ste20-like kinase, SLK, activity: Dimerization and activation segment phosphorylation.

Authors:  Andrey V Cybulsky; Julie Guillemette; Joan Papillon; Nihad T Abouelazm
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

5.  Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness.

Authors:  Benjamin R Pryce; Khalid N Al-Zahrani; Sébastien Dufresne; Natalya Belkina; Cédrik Labrèche; Genaro Patino-Lopez; Jérôme Frenette; Stephen Shaw; Luc A Sabourin
Journal:  Skelet Muscle       Date:  2017-02-02       Impact factor: 4.912

6.  Transforming growth factor β-induced epithelial to mesenchymal transition requires the Ste20-like kinase SLK independently of its catalytic activity.

Authors:  Jillian Conway; Khalid N Al-Zahrani; Benjamin R Pryce; John Abou-Hamad; Luc A Sabourin
Journal:  Oncotarget       Date:  2017-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.